Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Maggiolo

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settingsDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2016
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized TrialsÁlvaro H Borges, Andreas Lundh, Britta Tendal, et al.
Journal of Hepatology|August 22, 2019
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, Angiola Spinetti, Andrea Lombardi, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settingsDaniele Armenia, Yagai Bouba, Roberta Gagliardini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2016
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized TrialsÁlvaro H Borges, Andreas Lundh, Britta Tendal, et al.
Journal of Hepatology|August 22, 2019
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failureElisabetta Degasperi, Angiola Spinetti, Andrea Lombardi, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Journal of Hepatology|November 26, 2018
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D'Ambrosio, Luisa Pasulo, Massimo Puoti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Pageof 15